Richard Vellacott

Richard has over 15 years’ experience as a chartered accountant, working with life science companies from start-ups to global pharmaceuticals. He also has a first class degree in biological sciences from Durham University.

Past roles include Vice President, Finance at CSR plc, a listed hi-tech company with revenues of $1bn. During his time at CSR Richard had worldwide responsibility for finance, making significant contributions to the transformational acquisition and integration of a NASDAQ listed Zoran Corp., product portfolio management, R&D budgeting and business investment / divestment decisions.

Before this, Richard was a Director in Deloitte’s life sciences practice, where he specialized in capital market transactions including IPOs, M&A and fundraising on both the UK and the US markets.

Beyond his corporate responsibilities, Richard has advised the EC on funding for life science companies and presented at investor conferences and technical seminars on financial issues facing the life science industry.

Richard Vellacott is the Chief Financial Officer at Horizon Discovery, based in United States, North America. With a background in Biotechnology, Richard Vellacott has a rich history of leadership and innovation.Richard Vellacott studied Certificate Biological Sciences at Durham University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.